每经AI快讯，11月23日，禾元生物公告，公司于2025年11月21日召开第四届董事会第十一次会议，审议 通过了关于使用部分闲置募集资金进行现金管理的议案。公司拟使用不超过21亿元的暂时闲置募集资金 (含超募资金)购买安全性高、流动性好的保本型产品，包括但不限于协定性存款、结构性存款、定期存 款、通知存款、大额存单等。该额度自董事会审议通过之日起12个月内有效，在额度范围内可滚动使 用。公司明确，此次现金管理不会影响募集资金投资项目进度和公司正常生产经营，所得收益将优先用 于补足募投项目投资不足及补充流动资金，并按规定归还至募集资金专户。 ...

南财智讯11月23日电，禾元生物公告，公司于2025年11月21日召开第四届董事会第十一次会议，审议通 过了关于使用部分闲置募集资金进行现金管理的议案。公司拟使用不超过21.00亿元的暂时闲置募集资 金（含超募资金）购买安全性高、流动性好的保本型产品，包括但不限于协定性存款、结构性存款、定 期存款、通知存款、大额存单等。该额度自董事会审议通过之日起12个月内有效，在额度范围内可滚动 使用。公司明确，此次现金管理不会影响募集资金投资项目进度和公司正常生产经营，所得收益将优先 用于补足募投项目投资不足及补充流动资金，并按规定归还至募集资金专户。 ...

南财智讯11月20日电，英特科技公告，公司于2025年11月20日召开第二届董事会审计委员会第十次会议 和第二届董事会第十九次会议，审议通过了《关于公司使用部分闲置募集资金（含超募资金）进行现金 管理的议案》。为提高资金使用效益，公司拟使用不超过人民币1.40亿元的暂时闲置募集资金进行现金 管理，投资于安全性高、流动性好的投资产品，包括但不限于结构性存款、协定存款、通知存款、大额 存单、收益凭证等。该事项尚需提交公司2025年第二次临时股东会审议通过，额度自股东会审议通过之 日起12个月内有效，在前述额度和期限范围内可滚动使用，且单个产品的投资期限不得超过12个月。公 司表示，本次现金管理不会影响募集资金投资项目进度和公司正常生产经营。 ...

智通财经11月20日讯诚达药业股份有限公司（证券代码：301201，简称"诚达药业"）今日发布公告称， 公司第六届董事会第二次会议已于11月19日审议通过《关于使用闲置自有资金进行现金管理的议案》， 拟使用不超过7亿元闲置自有资金进行低风险现金管理，以提升资金使用效率。该议案尚需提交公司股 东会审议，资金使用期限为股东会审议通过之日起12个月，期间可循环滚动使用。 投资方案：聚焦低风险流动性产品 公告显示，本次现金管理的投资品种将严格限定为风险较低、流动性好、期限不超过12个月的金融产 品，具体包括协定存款、通知存款、定期存款、结构性存款及金融机构理财产品等。公司明确表示，投 资产品不用于质押，亦不涉及以证券投资为目的的投资行为，且与理财产品发行主体无关联关系。 在额度与期限方面，公司及子公司合计投资上限为7亿元（含本数），资金可在上述额度及12个月有效 期内循环使用。公司董事会提请股东会授权管理层在额度范围内行使决策权，具体由财务部负责组织实 施。 风险控制：多重机制保障资金安全 尽管投资标的为低风险产品，公司仍针对潜在风险制定了系列控制措施： -动态跟踪机制：管理层及财 务部将持续监控产品投向与项目进展， ...

南财智讯11月19日电，诚达药业公告，公司于2025年11月19日召开第六届董事会第二次会议，审议通过 了《关于使用闲置募集资金进行现金管理的议案》。公司拟使用不超过人民币8.00亿元的暂时闲置募集 资金（含超募资金）进行现金管理，投资于安全性高、流动性好、期限不超过12个月的产品，包括但不 限于协定存款、通知存款、定期存款、结构性存款等现金管理类产品。使用期限自股东会审议通过之日 起12个月内有效，资金在额度范围内可滚动使用。该事项尚需提交公司股东会审议，不会影响募集资金 投资项目进度和公司正常生产经营。 ...

Core Viewpoint - The company plans to utilize idle raised funds for cash management, aiming to enhance the efficiency of fund usage and maximize shareholder returns while ensuring the safety of the funds [2][3][16]. Investment Overview - **Investment Purpose**: To improve the efficiency of raised funds and increase cash asset returns without affecting the normal implementation of investment projects [3]. - **Investment Amount**: The company intends to use up to RMB 600 million (including principal) of idle raised funds for cash management within 12 months from the board meeting approval [4][11]. - **Source of Funds**: The funds for cash management will come from temporarily idle raised funds from the company's initial public offering [5]. Investment Products - **Types of Investments**: The company will invest in high-security, liquid financial products, including but not limited to agreement deposits, structured deposits, time deposits, notice deposits, and large-denomination certificates of deposit [2][9]. - **Implementation Method**: After board approval, the management is authorized to make decisions regarding the selection of investment products and sign relevant legal documents [9]. Cash Management and Returns - **Return Distribution**: The income from cash management will be used primarily to cover any shortfall in investment amounts for projects and for the company's operational liquidity needs [9][16]. - **Recent Cash Management**: In the past 12 months, the company has also approved the use of up to RMB 650 million for cash management, indicating a consistent strategy to manage idle funds [10][11]. Risk Control Measures - **Risk Management**: The company will adhere to strict regulations and guidelines to ensure the safety of funds, including selecting reputable issuers and monitoring investment performance [15]. - **Supervision**: Independent directors and the audit committee will oversee the use of funds, with the option to hire professional auditors if necessary [15]. Impact on the Company - **Operational Impact**: The cash management initiative will not affect the company's daily operations or the progress of investment projects, aiming to enhance fund efficiency and shareholder returns [16][17]. - **Regulatory Compliance**: The cash management activities comply with relevant laws and regulations, ensuring no change in the intended use of raised funds [17][18].

Core Viewpoint - The company plans to utilize temporarily idle raised funds for cash management, ensuring safety and liquidity while aiming to enhance returns for the company and its shareholders [2][3][20]. Investment Overview - **Investment Purpose**: The objective is to improve the efficiency of raised funds, ensuring that the use of these funds does not affect project construction and safety, while increasing returns for the company and shareholders [3]. - **Investment Amount**: The company intends to use up to RMB 300 million (including principal) for cash management, with a validity period of 12 months from the board's approval [4][16]. - **Source of Funds**: The cash management funds will come from temporarily idle raised funds from the company's initial public offering in 2019 [5]. Fund Management - **Fund Usage**: The raised funds from the IPO amounted to RMB 1,588.29 million, with a net amount of RMB 1,529.27 million after deducting issuance costs. All funds have been deposited in a special account approved by the board [6][24]. - **Investment Projects**: The raised funds are allocated for international pharmaceutical R&D and working capital, with adjustments made to project timelines as necessary [7][23]. Investment Methodology - **Investment Products**: The company will invest in low-risk, liquid, and capital-protected products such as agreement deposits, notice deposits, time deposits, large certificates of deposit, and income certificates, with a maximum term of 12 months [10][16]. - **Implementation**: The board authorizes the management to make investment decisions within the approved limits and timeframe, with the finance department responsible for execution [11]. Cash Management Returns - **Return Allocation**: Earnings from cash management will be prioritized to cover any shortfalls in project investment amounts and will be managed according to regulatory requirements [12]. Recent Cash Management Situation - **Recent 12-Month Overview**: The authorization for cash management is valid for 12 months, allowing for rolling use of funds within the specified limits [13][14]. Board Approval Process - **Approval Details**: The board approved the cash management proposal on November 7, 2025, confirming that it would not affect the normal operation of the company's investment plans [15][21]. Impact on Company - **Operational Impact**: The planned cash management will not affect the normal operations or project funding of the company, and it aims to generate additional investment returns [20][29].

Core Viewpoint - The company plans to utilize temporarily idle raised funds for cash management to enhance fund efficiency and generate additional returns for the company and its shareholders [3][9][18]. Investment Overview - **Investment Purpose**: The aim is to improve the efficiency of raised fund usage while ensuring that it does not affect the construction and use of the raised fund projects [3]. - **Investment Amount**: The company intends to use up to RMB 300 million (including principal) for cash management, with a validity period of 12 months from the board's approval [4][14]. - **Source of Funds**: The funds for this cash management initiative come from the temporarily idle raised funds from the company's initial public offering in 2019 [5]. Investment Details - **Investment Products**: The company will invest in low-risk, liquid, and capital-protected financial products, including but not limited to agreement deposits, notice deposits, time deposits, large certificates of deposit, and income certificates [2][10]. - **Implementation Method**: The board authorizes the management to make investment decisions within the approved limits and timeframe, with the finance department responsible for execution [11][14]. Recent Cash Management Situation - The company has previously authorized cash management of up to RMB 400 million, with the latest authorization allowing for up to RMB 300 million [13][26]. Impact on the Company - The planned cash management will not affect the normal operation of the company's main business or the normal turnover of funds, and it aims to generate investment returns for the company and its shareholders [18][20]. Sponsor's Verification Opinion - The sponsor, UBS Securities, has confirmed that the cash management initiative has been approved by the board and complies with relevant laws and regulations, ensuring that it does not alter the intended use of raised funds [19][20].

Core Viewpoint - The company plans to utilize part of its idle raised funds for cash management, with a maximum amount of RMB 600 million, ensuring that it does not affect the implementation of fundraising projects and guarantees the safety of the raised funds [2][4][11]. Summary by Sections Basic Situation - Chengdu Sike Rui Microelectronics Co., Ltd. convened its 16th meeting of the second board of directors and the 11th meeting of the second supervisory board on October 29, 2025, to approve the proposal for cash management using idle raised funds [2]. - The total amount raised from the initial public offering (IPO) was RMB 1,388.25 million, with a net amount of RMB 1,252.51 million after deducting issuance costs [2]. Use of Raised Funds - The company disclosed that due to the construction cycle of fundraising investment projects, there is a temporary idle situation with part of the raised funds [3]. - The company aims to improve the efficiency of fund usage without affecting the normal operation of fundraising projects [4]. Investment Amount and Duration - The maximum amount for cash management is set at RMB 600 million, with an investment duration not exceeding 12 months [5][11]. Source of Funds - The source of the funds for cash management will be the raised funds [6]. Implementation Method - The board of directors has authorized the chairman and financial department staff to handle related matters within the specified limits and duration [7]. Types of Investment Products - The company will invest in high-safety, high-liquidity, and principal-protected investment products, including structured deposits, time deposits, notice deposits, and large-denomination certificates of deposit [8]. Information Disclosure - The company will comply with relevant regulations and timely fulfill information disclosure obligations [9]. Distribution of Cash Management Earnings - Earnings from cash management will be used to supplement insufficient investment amounts for fundraising projects and for the company's daily operational liquidity [10]. Impact on Daily Operations - The planned cash management will not affect the normal turnover of funds or the operation of fundraising investment projects, and it aims to enhance the efficiency of fund usage and increase returns for shareholders [11]. Review Procedures - The proposal for cash management was approved by the board of directors and the supervisory board, ensuring compliance with relevant regulations [14].

Core Viewpoint - Company Rongzhi Rixin (688768) has announced plans to utilize idle raised funds and self-owned funds for cash management and entrusted wealth management, aiming to enhance capital efficiency and comply with regulations [1][2]. Financial Performance - As of October 30, 2025, Rongzhi Rixin's stock closed at 47.48 yuan, down 3.42% from the previous trading day, with a total market capitalization of 4.178 billion yuan [1]. - The stock opened at 49.16 yuan, reached a high of 49.17 yuan, and a low of 47.08 yuan, with a trading volume of 1.01 billion yuan and a turnover rate of 2.42% [1]. Fund Management Plans - The company plans to use up to 73 million yuan of temporarily idle raised funds for cash management and up to 500 million yuan of self-owned funds for entrusted wealth management, with a usage period not exceeding 12 months from the board's approval [1]. - Idle raised funds can be invested in various principal-protected products, including structured deposits, agreed deposits, notice deposits, time deposits, large certificates of deposit, treasury reverse repos, and income certificates [1]. - Self-owned funds may be allocated to money market funds, trust products, and entrusted loans [1]. Regulatory Compliance - The board of directors has approved the aforementioned plans without the need for shareholder meeting approval [1]. - Guoyuan Securities, the sponsor, has issued a special verification opinion stating that the plans comply with relevant regulations and will not affect the normal implementation of fundraising projects, thus supporting the efficiency of fund utilization [1].